Sangamo(美國(guó))

Sangamo BioSciences

美國(guó)SangamoBioScienceswww.sangamo.comSangamoBioSciences,公司(Nasdaq:SGMO)是鋅指核酸酶研究領(lǐng)域的先鋒。SigmaLifeScience是其合作伙伴，因而是已獲驗(yàn)證的含ZFN技術(shù)研究試劑的來(lái)源 Sangamoisaclinicalstagebiopharmaceuticalcompanyfocusedontheresearch,deve lopmentandcommercializationofengineeredDNA-bindingproteinsforthedevelopmentofnoveltherapeuticstrategiesforunmetmedicalneeds.Weareworldwideleadersinthedevelopmentofaproprietarytechnologyplatformthatenablesspecificregulationofgeneexpressionandgenemodification.Thebasisofthisplatformisanaturallyoccurringclassoftranscriptionfactors,zincfingerDNA-bindingproteins(ZFPs)whichwecanengineertodrivedesiredtherapeuticoutcomes.EngineeredZFPscanbelinkedtofunctionaldomainsthatnormallyactivateorrepressgeneexpressiontocreateZFPtranscriptionfactors(ZFPTFs)capableofturninggenesonoroff.WecanalsolinkZFPstonucleasedomainstocreatezincfingernucle